172 related articles for article (PubMed ID: 20026502)
1. Childhood polyarteritis nodosa in autoimmune lymphoproliferative syndrome.
Naumann-Bartsch N; Stachel D; Morhart P; Staatz G; Jüngert J; Schwarz K; Holter W
Pediatrics; 2010 Jan; 125(1):e169-73. PubMed ID: 20026502
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
[TBL] [Abstract][Full Text] [Related]
3. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
4. Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome.
Glerup M; Herlin T; Rittig S; Grønbæk K; Hokland M; Hasle H
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e187-9. PubMed ID: 23588339
[TBL] [Abstract][Full Text] [Related]
5. Polyarteritis nodosa complicated by intrahepatic-perihepatic hemorrhage and acute appendicitis: successful treatment with cyclophosphamide and corticosteroids.
Kart-Koseoglu H; Yucel AE; Aytekin C; Sahin B
Clin Rheumatol; 2003 Sep; 22(3):251-3. PubMed ID: 14505223
[TBL] [Abstract][Full Text] [Related]
6. [Familial splenomegaly as a first clinical sign of autoimmune lymphoproliferative syndrome].
Bilbao Aburto A; Arana Aguirre N; García Martínez JM; Astigarraga Aguirre I; Allende LM
An Pediatr (Barc); 2010 Apr; 72(4):278-81. PubMed ID: 20227933
[TBL] [Abstract][Full Text] [Related]
7. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ
Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
[TBL] [Abstract][Full Text] [Related]
9. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
10. Seckel syndrome with polyarteritis nodosa.
Kutlu R; Alkan A; Kutlu O; Yakinci C
Indian Pediatr; 2004 Nov; 41(11):1158-61. PubMed ID: 15591669
[TBL] [Abstract][Full Text] [Related]
11. Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome.
Bajwa R; Savelli S; Gross T
Pediatr Blood Cancer; 2011 Aug; 57(2):336-7. PubMed ID: 21495163
[TBL] [Abstract][Full Text] [Related]
12. Polyarteritis nodosa in a patient with type 1 autoimmune hepatitis.
Giouleme O; Mpoumponaris A; Aslanidis S; Anagnostis P; Giamalis P; Nikolaidis N; Vasiliadis T; Evgenidis N
South Med J; 2011 Jan; 104(1):49-52. PubMed ID: 21119556
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature.
Oren H; Ozkal S; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Kargi A; Irken G
Ann Hematol; 2002 Nov; 81(11):651-3. PubMed ID: 12454704
[TBL] [Abstract][Full Text] [Related]
14. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study.
Seif AE; Manno CS; Sheen C; Grupp SA; Teachey DT
Blood; 2010 Mar; 115(11):2142-5. PubMed ID: 20068224
[TBL] [Abstract][Full Text] [Related]
15. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
17. Cranial nerve involvement with juvenile polyarteritis nodosa: clinical manifestations and treatment.
Wahezi DM; Gomes WA; Ilowite NT
Pediatrics; 2010 Sep; 126(3):e719-22. PubMed ID: 20732942
[TBL] [Abstract][Full Text] [Related]
18. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
19. Polyarteritis nodosa presenting with necrotising appendicitis and hepatic aneurysm rupture.
Ozçay N; Arda K; Sugüneş T; Ozdemirel D; Aydoğ G; Atalay F; Akoğlu M
Turk J Gastroenterol; 2003 Mar; 14(1):68-70. PubMed ID: 14593542
[TBL] [Abstract][Full Text] [Related]
20. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
